KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLoans and Notes ReceivablesLong-Term Debt IssuancesNon-Current ReceivablesReceivables RefundsShares OutstandingShares Repurchased
Ratios

Royalty Pharma (RPRX) Shares Outstanding (2020 - 2025)

Historic Shares Outstanding for Royalty Pharma (RPRX) over the last 6 years, with Q3 2025 value amounting to $429.0 million.

  • Royalty Pharma's Shares Outstanding fell 381.38% to $429.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $429.0 million, marking a year-over-year decrease of 381.38%. This contributed to the annual value of $446.0 million for FY2024, which is 15.83% down from last year.
  • Per Royalty Pharma's latest filing, its Shares Outstanding stood at $429.0 million for Q3 2025, which was down 381.38% from $432.3 million recorded in Q2 2025.
  • Royalty Pharma's 5-year Shares Outstanding high stood at $451.0 million for Q1 2024, and its period low was $392.9 million during Q1 2021.
  • For the 5-year period, Royalty Pharma's Shares Outstanding averaged around $437.3 million, with its median value being $441.1 million (2022).
  • Per our database at Business Quant, Royalty Pharma's Shares Outstanding surged by 1670.05% in 2021 and then crashed by 563.02% in 2025.
  • Quarter analysis of 5 years shows Royalty Pharma's Shares Outstanding stood at $433.0 million in 2021, then grew by 2.36% to $443.2 million in 2022, then grew by 0.8% to $446.7 million in 2023, then decreased by 0.16% to $446.0 million in 2024, then fell by 3.8% to $429.0 million in 2025.
  • Its Shares Outstanding stands at $429.0 million for Q3 2025, versus $432.3 million for Q2 2025 and $425.6 million for Q1 2025.